Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Furlanut

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Human Toxicology|December 1, 1984
Cyanotic crises in a breast-fed infant from mother taking dipyroneG Rizzoni, M Furlanut
Pharmacological Research|March 30, 1999
Pharmacodynamic modelling of levodopa, 3-O-methyldopa and their effects: an application of the Dixon equationG Wu, M Furlanut
Oncology|October 31, 2003
Pharmacology of ifosfamideM Furlanut, L Franceschi
Clinical Pharmacokinetics|December 12, 2001
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactionsF Pea, M Furlanut
Pharmacological Research|January 1, 1990
The pharmacokinetics of tricyclic antidepressant drugs in the elderlyM Furlanut, P Benetello
International Journal of Clinical Pharmacology Research|January 1, 1996
Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by means of total, lean and different adipose factors dosing body weight using Bayesian and non-linear least squares methodsG Wu, M Furlanut
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1973
Effects of diphenylhydantoin on smooth muscleM Ferrari, M Furlanut
Acta Neurologica Belgica|November 2, 1999
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's diseaseG Wu, M Baraldo, M Furlanut
La Clinica Terapeutica|April 15, 1978
[Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy]P Benetello, G Testa, M Furlanut
Biochemical Pharmacology|October 15, 1973
Effects of some isoquinoline compounds and certain derivatives on brain phosphodiesterase activityM Furlanut, F Carpenedo, M Ferrari
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Human Toxicology|December 1, 1984
Cyanotic crises in a breast-fed infant from mother taking dipyroneG Rizzoni, M Furlanut
Pharmacological Research|March 30, 1999
Pharmacodynamic modelling of levodopa, 3-O-methyldopa and their effects: an application of the Dixon equationG Wu, M Furlanut
Oncology|October 31, 2003
Pharmacology of ifosfamideM Furlanut, L Franceschi
Clinical Pharmacokinetics|December 12, 2001
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactionsF Pea, M Furlanut
Pharmacological Research|January 1, 1990
The pharmacokinetics of tricyclic antidepressant drugs in the elderlyM Furlanut, P Benetello
International Journal of Clinical Pharmacology Research|January 1, 1996
Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by means of total, lean and different adipose factors dosing body weight using Bayesian and non-linear least squares methodsG Wu, M Furlanut
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1973
Effects of diphenylhydantoin on smooth muscleM Ferrari, M Furlanut
Acta Neurologica Belgica|November 2, 1999
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's diseaseG Wu, M Baraldo, M Furlanut
La Clinica Terapeutica|April 15, 1978
[Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy]P Benetello, G Testa, M Furlanut
Biochemical Pharmacology|October 15, 1973
Effects of some isoquinoline compounds and certain derivatives on brain phosphodiesterase activityM Furlanut, F Carpenedo, M Ferrari
Pageof 10